Sanofi SG&A Expenses 2010-2025 | SNY

Sanofi sg&a expenses for the twelve months ending March 31, 2025 were $9.450B, a 18.55% decline year-over-year.

  • Sanofi annual sg&a expenses for 2024 were $9.937B, a 14.13% decline from 2023.
  • Sanofi annual sg&a expenses for 2023 were $11.572B, a 4.68% increase from 2022.
  • Sanofi annual sg&a expenses for 2022 were $11.054B, a 2.21% decline from 2021.

Sanofi SG&A Expenses 2010-2025 | SNY

  • Sanofi annual sg&a expenses for 2024 were $9.937B, a 14.13% decline from 2023.
  • Sanofi annual sg&a expenses for 2023 were $11.572B, a 4.68% increase from 2022.
  • Sanofi annual sg&a expenses for 2022 were $11.054B, a 2.21% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B